Congenital heart diseaseCohort study
Pulmonary Atresia With Intact Septum Survival, Reintervention, and Days in Hospital Through Childhood: Contemporary Outcomes From a National Registry
- national registry
- linked to multiple national data sets
- England and Wales
- 2000-2022
Authors' conclusion
In a contemporary pulmonary atresia with intact ventricular septum cohort, transcatheter right ventricular decompression was the predominant initial intervention. This approach had lower in-hospital mortality compared with older multicenter series, with BiV repair achieved in more than half of the patients. Early mortality after nonantegrade flow augmentation remains high, likely due to nonmodifiable risk factors in severe cases. Long-term survival and hospital stay remain better for those amenable to BiV circulation, reflecting more favorable anatomy compared with those on the single-ventricle pathway, although reintervention is lower in the latter.
Study context
- Population
- Patients aged 0 to 18 years with pulmonary atresia with intact ventricular septum undergoing cardiac intervention
- Participants
- 488 included patients
- Exposure
- Outcomes overall and by treatment pathway
Main finding
As reported in the abstract
right ventricular decompression as the first procedure
58.8%
of those, transcatheter
84.8%
stage 1 palliation
32.4%
died or were lost to follow-up before either intervention
8.8%
Observational data: associations, not effects.
Further findings
| Outcome | right ventricular decompression | stage 1 palliation |
|---|---|---|
| 1-year mortality by initial therapy | 7.7% (interval 4.5%–10.7%) | 37.2% (interval 29.0%–44.5%) |
days
- Median hospital stay — first year
- 35
- Median hospital stay — annually by 10 years
- 2
- Cardiac reintervention: after biventricular (BiV) repair 62.6% (interval 56.1%–68.4%)
- Cardiac reintervention: after palliative stage 3 32.8% (interval 21.5%–44.4%)
- Median hospital stay: functionally single-ventricle 52
- Median hospital stay: BiV 28
Final pathway
- achieved biventricular (BiV) repair
- 54.5%
- functionally single-ventricle palliation
- 26.7%
- noncommitted
- 18.8%
In-hospital mortality
- Overall group in-hospital mortality
- 11.7%
Mortality · 1 and 5 years; median follow-up 8.9 years
- 1-year mortality
- 19.8% (95% CI, 16.2%-23.2%)
- 5-year mortality
- 20.8% (95% CI, 17.1%-24.4%)
Original publication
Summarised from the published abstract; every number is checked against it